At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions : A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ClinicalTrials.gov - (2024) vom: 18. Apr. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: August 29, 2013, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024 |
---|
Study ID: |
NCT01931644 |
---|---|
Veröffentlichungen zur Studie: |
|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG001507613 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG001507613 | ||
003 | DE-627 | ||
005 | 20240424010330.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210408s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG001507613 | ||
035 | |a (UBBS_Klinische_Studien)NCT01931644 | ||
035 | |a (UBBS_Klinische_Studien)SAN-BB-01 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |b A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: August 29, 2013, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024 | ||
520 | |a This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology. | ||
650 | 2 | |a Hepatitis B | |
650 | 2 | |a Spondylitis | |
650 | 2 | |a Acquired Immunodeficiency Syndrome | |
650 | 2 | |a HIV Infections | |
650 | 2 | |a Prostatic Neoplasms | |
650 | 2 | |a Colorectal Neoplasms | |
650 | 2 | |a Melanoma | |
650 | 2 | |a Multiple Myeloma | |
650 | 2 | |a Pancreatic Neoplasms | |
650 | 2 | |a Ovarian Neoplasms | |
650 | 2 | |a Uterine Cervical Neoplasms | |
650 | 2 | |a Colonic Neoplasms | |
650 | 2 | |a Kidney Neoplasms | |
650 | 2 | |a Carcinoma, Renal Cell | |
650 | 2 | |a Skin Neoplasms | |
650 | 2 | |a Papilloma | |
650 | 2 | |a Arthritis | |
650 | 2 | |a Muscular Dystrophies | |
650 | 2 | |a Arthritis, Psoriatic | |
650 | 2 | |a Spondylarthritis | |
650 | 2 | |a Muscular Dystrophy, Duchenne | |
650 | 2 | |a Spondylitis, Ankylosing | |
650 | 2 | |a Sjogren's Syndrome | |
650 | 2 | |a Myotonic Dystrophy | |
650 | 2 | |a Myositis | |
650 | 2 | |a Muscular Dystrophy, Facioscapulohumeral | |
650 | 2 | |a Hepatitis | |
650 | 2 | |a Cystic Fibrosis | |
650 | 2 | |a Crohn Disease | |
650 | 2 | |a Colitis | |
650 | 2 | |a Colitis, Ulcerative | |
650 | 2 | |a Celiac Disease | |
650 | 2 | |a Lung Diseases | |
650 | 2 | |a Lung Diseases, Obstructive | |
650 | 2 | |a Pulmonary Disease, Chronic Obstructive | |
650 | 2 | |a Parkinson Disease | |
650 | 2 | |a Multiple Sclerosis | |
650 | 2 | |a Epilepsy | |
650 | 2 | |a Muscular Atrophy | |
650 | 2 | |a Huntington Disease | |
650 | 2 | |a Polyneuropathies | |
650 | 2 | |a Muscular Atrophy, Spinal | |
650 | 2 | |a Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | |
650 | 2 | |a Down Syndrome | |
650 | 2 | |a Kidney Diseases | |
650 | 2 | |a Renal Insufficiency, Chronic | |
650 | 2 | |a Endometriosis | |
650 | 2 | |a Nephritis | |
650 | 2 | |a Lupus Nephritis | |
650 | 2 | |a Polycystic Kidney Diseases | |
650 | 2 | |a Telangiectasis | |
650 | 2 | |a Telangiectasia, Hereditary Hemorrhagic | |
650 | 2 | |a Thalassemia | |
650 | 2 | |a Purpura | |
650 | 2 | |a Purpura, Thrombocytopenic | |
650 | 2 | |a Anemia, Sickle Cell | |
650 | 2 | |a beta-Thalassemia | |
650 | 2 | |a Purpura, Thrombocytopenic, Idiopathic | |
650 | 2 | |a Purpura, Thrombotic Thrombocytopenic | |
650 | 2 | |a Glucosephosphate Dehydrogenase Deficiency | |
650 | 2 | |a Sickle Cell Trait | |
650 | 2 | |a Dermatitis, Atopic | |
650 | 2 | |a Psoriasis | |
650 | 2 | |a Dermatitis | |
650 | 2 | |a Eczema | |
650 | 2 | |a Lupus Erythematosus, Systemic | |
650 | 2 | |a Alopecia | |
650 | 2 | |a Alopecia Areata | |
650 | 2 | |a Scleroderma, Systemic | |
650 | 2 | |a Scleroderma, Diffuse | |
650 | 2 | |a Rosacea | |
650 | 2 | |a Sclerosis | |
650 | 2 | |a Fibrosis | |
650 | 2 | |a Disease | |
650 | 2 | |a Atrophy | |
650 | 2 | |a Trisomy | |
650 | 2 | |a Depression | |
650 | 2 | |a Bipolar Disorder | |
650 | 2 | |a Anxiety Disorders | |
650 | 4 | |a Study Type: Observational | |
650 | 4 | |a Recruitment Status: Completed | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 18. Apr. |
773 | 1 | 8 | |g year:2024 |g day:18 |g month:04 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT01931644 |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2024 |b 18 |c 04 |